U.S. FDA gives green signal for the first generic EpiPen alternative
Date: 2018-08-17   Author: Saif Ali Bepari  Category: #technology

U.S. FDA gives green signal for the first generic EpiPen alternative

The U.S. FDA has reportedly announced that it has provided the approval for an alternative of the generic EpiPen that has been touted to help individuals with severe allergies. According to sources, the generic EpiPen alternate has been developed by the U.S. arm of an Israeli company – Teva Pharmaceuticals.

For the uninitiated, Teva’s alternative is reportedly deemed to be an equivalent of the EpiPen and can be automatically substituted for the EpiPen & EpiPen Jr. prescriptions at the pharmacy counter.

According to an official press release by the FDA, the new alternative is an auto-injector for treating allergic reactions in an emergency including life threatening situations like anaphylaxis and is meant for children & adults who are above 33 pounds (minimum weight limit).

FDA Commissioner & M.D. Scott Gottlieb stated that the approval is a part of the FDA’s long-standing commitment of making affordable, safe and effective alternatives for different medicines commercially available. Gottlieb further added that individuals requiring access to the life-saving epinephrine because of their severe allergies now have an affordable, FDA certified alternative.

According to reports, EpiPens, manufactured by pharma giant Mylan, is currently experiencing a shortfall due to major manufacturing and supply issues. In consequence, EpiPens made it to the FDA’s list of drug shortages list on the 9th of May 2018. In the backdrop of this scenario, the new alternative from Teva is certain to be a lifesaver, claim experts familiar with the matter.

Incidentally, the EpiPen alternative had to undergo a rigorous trial to receive the approval from the FDA. One of the main reasons behind the delay for approval has been speculated to be the drug’s nature that is complex generic – in the sense, the product is inclusive of both, a drug and an injector device.

The approval is a victory for the FDA as the Trump administration strives to achieve their promise of lowering medicine prices.



About Author


Saif Ali Bepari

Saif Ali Bepari

Saif currently works as a content writer at Algosonline. A Computer Science graduate who has a zest for writing over coding, commenced his journey in the writing industry as a freelancer. Having had a prior freelance experience, he has tinkered with creative writing, ...

Read More

More from Saif


Post Recommendents

Lepidolite Market 2024 | Hallgarten and Company, SVS Chemical, Hangzhou J&H Chemical Company Limited, Lithium Australia NL and Univar
Author: Rahul Varpe

Global Lepidolite Market size is anticipated to witness a healthy CAGR during the forecast period. Lepidolite is mica mineral made of potassium, aluminum silicates and lithium. It is an ore of lithium which is usually violet colored, depending on ...


Emulsion Styrene Butadiene Elastomer Market 2024 | Lanxess, Sinopec, Goodyear Tire and Rubber company, CNPC and Zeon
Author: Rahul Varpe

North America, led by the U.S. emulsion styrene butadiene elastomer market size may witness steady growth. Rise in tire manufacturers along with increasing R&D spending  should drive regional growth. Increasing E-SBR demand in adhesives a...


An Inherent Overview Of Stand-Up Pouch Valves Market In Terms Of The Technological Advancements
Author: Rahul Varpe

Global Stand-Up Pouch Valves Market Size, Share and Forecast 2024 released By Global Market Insights, Inc. Report provides Market information about industry Top Key Players, Countries, Type and Application. This Strategy Consulting report also sta...